Abstract:Graphical and Lay Summary RNA polymerases (RNAPs) are used to produce mRNA for therapeutic purposes, however the toolbox of available RNAPs is limited. In this work, a high throughput cell free screening system is introduced, that allows for the rapid characterization of putative RNAPs. 8 novel RNAPs are described, in addition to providing a means by which new or engineered RNAPs can be rapidly assessed for their suitability for mRNA manufacture. All mRNA products are currently manufactured in in vitro transcription (IVT) reactions that utilize single‐subunit RNA polymerase (RNAP) biocatalysts. Although it is known that discrete polymerases exhibit highly variable bioproduction phenotypes, including different relative processivity rates and impurity generation profiles, only a handful of enzymes are generally available for mRNA biosynthesis. This limited RNAP toolbox restricts strategies to design and troubleshoot new mRNA manufacturing processes, which is particularly undesirable given the continuing diversification of mRNA product lines toward larger and more complex molecules. Herein, we describe development of a high‐throughput RNAP screening platform, comprising complementary in silico and in vitro testing modules, that enables functional characterization of large enzyme libraries. Utilizing this system, we identified eight novel sequence‐diverse RNAPs, with associated active cognate promoters, and subsequently validated their performance as recombinant enzymes in IVT‐based mRNA production processes. By increasing the number of available characterized functional RNAPs by more than 130% and providing a platform to rapidly identify further potentially useful enzymes, this work significantly expands the RNAP biocatalyst solution space for mRNA manufacture, thereby enhancing the capability for application‐specific and molecule‐specific optimization of both product yield and quality.

Advances in evolved T7 RNA polymerases for expanding the frontiers of enzymatic nucleic acid synthesis

An engineered T7 RNA Polymerase for efficient co-transcriptional capping with reduced dsRNA byproducts in mRNA synthesis

Promoter-independent synthesis of chemically modified RNA by human DNA polymerase θ variants

RNA-based Therapeutics: an Overview and Prospectus

Engineered Stop and Go T7 RNA Polymerases

Enzymatic synthesis of base-modified RNA by T7 RNA polymerase. A systematic study and comparison of 5-substituted pyrimidine and 7-substituted 7-deazapurine nucleoside triphosphates as substrates.

Research Progress on Enzymatic Synthesis of RNA

Expanding the RNA polymerase biocatalyst solution space for mRNA manufacture

Directed evolution of a highly efficient TNA polymerase achieved by homologous recombination

Bacteriophage T7 Transcription System: an Enabling Tool in Synthetic Biology.

Recent Advances and Prospects in RNA Drug Development

Expedient production of site specifically nucleobase-labelled or hypermodified RNA with engineered thermophilic DNA polymerases

Evolution of C‐Terminal Modification Tolerance in Full‐Length and Split T7 RNA Polymerase Biosensors

RNA Base Editors: the Emerging Approach of RNA Therapeutics.

Engineering synthetic RNA devices for cell control

Template-independent enzymatic synthesis of RNA oligonucleotides

Advances in Chemical Synthesis of Structurally Modified Bioactive RNAs

An RNA Polymerase from the Ocean Improves in Vitro RNA Synthesis (560.1)

Innovative developments and emerging technologies in RNA therapeutics

DNA-terminus-dependent transcription by T7 RNA polymerase and its C-helix mutants.